Ketoconazole and Posaconazole interaction

Ketoconazole and Posaconazole: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Ketoconazole label · effective 2026-07-07

Major

Ketoconazole tablets should be used only when other effective antifungal therapy is not available or tolerated and the potential benefits are considered to outweigh the potential risks.

Boxed warningby drug classView label on DailyMed
Minor

This effect is not shared with other azoles.

Warningsby drug classView label on DailyMed

From the Posaconazole (NOXAFIL) label · effective 2026-02-13

Major

Known hypersensitivity to posaconazole or other azole antifungal agents.

Contraindicationsby drug classView label on DailyMed
Major

Hypersensitivity Noxafil is contraindicated in persons with known hypersensitivity to posaconazole or other azole antifungal agents.

Contraindicationsby drug classView label on DailyMed
Minor

Effects of Noxafil and Noxafil PowderMix on Other Drugs Posaconazole is a strong CYP3A4 inhibitor.

Drug interactionsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.